+

WO1999046375A3 - Menschliche nukleinsäuresequenzen aus prostatagewebe - Google Patents

Menschliche nukleinsäuresequenzen aus prostatagewebe Download PDF

Info

Publication number
WO1999046375A3
WO1999046375A3 PCT/DE1999/000722 DE9900722W WO9946375A3 WO 1999046375 A3 WO1999046375 A3 WO 1999046375A3 DE 9900722 W DE9900722 W DE 9900722W WO 9946375 A3 WO9946375 A3 WO 9946375A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
prostate tissue
human nucleic
sequences
Prior art date
Application number
PCT/DE1999/000722
Other languages
English (en)
French (fr)
Other versions
WO1999046375A2 (de
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Original Assignee
Metagen Gesellschaft Fuer Genomforschung Mbh
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagen Gesellschaft Fuer Genomforschung Mbh, Thomas Specht, Bernd Hinzmann, Armin Schmitt, Christian Pilarsky, Edgar Dahl, Andre Rosenthal filed Critical Metagen Gesellschaft Fuer Genomforschung Mbh
Priority to JP2000535742A priority Critical patent/JP2002505878A/ja
Priority to EP99920546A priority patent/EP1068318A2/de
Publication of WO1999046375A2 publication Critical patent/WO1999046375A2/de
Publication of WO1999046375A3 publication Critical patent/WO1999046375A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Es werden menschliche Nukleinsäurequenzen - mRNA, cDNA, genomische Sequenzen - aus normalem Prostatagewebe, die für Genprodukte oder Teile davon kodieren und deren Verwendung beschrieben. Es werden weiterhin die über die Sequenzen erhältlichen Polypeptide und deren Verwendung beschrieben.
PCT/DE1999/000722 1998-03-10 1999-03-09 Menschliche nukleinsäuresequenzen aus prostatagewebe WO1999046375A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000535742A JP2002505878A (ja) 1998-03-10 1999-03-09 前立腺組織由来のヒト核酸配列
EP99920546A EP1068318A2 (de) 1998-03-10 1999-03-09 Menschliche nukleinsäuresequenzen aus prostatagewebe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19811194.0 1998-03-10
DE19811194A DE19811194A1 (de) 1998-03-10 1998-03-10 Menschliche Nukleinsäuresequenzen aus Prostatagewebe

Publications (2)

Publication Number Publication Date
WO1999046375A2 WO1999046375A2 (de) 1999-09-16
WO1999046375A3 true WO1999046375A3 (de) 2000-07-06

Family

ID=7860959

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000722 WO1999046375A2 (de) 1998-03-10 1999-03-09 Menschliche nukleinsäuresequenzen aus prostatagewebe

Country Status (4)

Country Link
EP (1) EP1068318A2 (de)
JP (1) JP2002505878A (de)
DE (1) DE19811194A1 (de)
WO (1) WO1999046375A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054987A1 (en) 1997-06-16 2003-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
WO2000052175A1 (en) 1999-03-04 2000-09-08 Merck Patent Gmbh Histidine protein-phosphatase
JP2004522402A (ja) * 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
AU2001247460A1 (en) * 2000-03-15 2001-09-24 Millennium Pharmaceuticals, Inc. 18615 and 48003, human ion channels and uses therefor
IL155244A0 (en) * 2000-10-30 2003-11-23 Bristol Myers Squibb Co Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
US20070172470A1 (en) * 2003-04-01 2007-07-26 The Regents Of The University Of California Phosphatase regulation of nucleic acid transcription

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036535A2 (en) * 1996-03-29 1997-10-09 Board Of Regents, The University Of Texas System Biomarkers for detection, diagnosis and prognosis of prostate cancer
WO1998004689A1 (en) * 1995-07-31 1998-02-05 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004689A1 (en) * 1995-07-31 1998-02-05 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO1997036535A2 (en) * 1996-03-29 1997-10-09 Board Of Regents, The University Of Texas System Biomarkers for detection, diagnosis and prognosis of prostate cancer
WO1999006548A2 (en) * 1997-08-01 1999-02-11 Genset 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"nj50f01.s1 NCI_CGAP_Pr9 Homo sapiens cDNA clone IMAGE:995929", EMBL DATABASE ENTRY HS1321049; ACCESSION NUMBER AA531076 (VERSION 2), 19 August 1997 (1997-08-19), XP002127855 *
"ns58d08.s1 NCI_CGAP_Pr22 Homom sapiens cDNA clone IMAGE:1187823", EMBL DATABASE ENTRY AA662096 (VERSION 2), 5 December 1997 (1997-12-05), XP002127857 *
BONFIELD, J. ET AL.: "A new sequence assembly program", NUCLEIC ACIDS RESEARCH., vol. 23, 1995, pages 4992-9, XP002127627, ISSN: 0305-1048 *
DONG, J.-T. ET AL.: "KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2", SCIENCE., vol. 268, 12 May 1995 (1995-05-12), pages 884 - 886, XP002127854 *
HILLIER, L. ET AL.: "WashU-Merck EST project 1997: zw53c09.r1 Soares total fetus Nb2HF8 9w Homo sapiens cDNA clone 773776 5'", EMBL DATABASE ENTRY HS1236638; ACCESSION NUMBER AA434549, 1 June 1997 (1997-06-01), XP002127856 *
HILLIER, L. ET AL.: "WashU-Merck EST project: yw79g09.s1 Homo sapiens cDNA clone 258496 3'", EMBL DATABASE ENTRY HS908263; ACCESSION NUMBER N25908, 30 December 1995 (1995-12-30), XP002127858 *
SCHULER, G. D.: "Sequence mapping by electronic PCR", GENOME RESEARCH., vol. 7, 1997, pages 541 - 550, XP002127628, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
EP1068318A2 (de) 2001-01-17
DE19811194A1 (de) 1999-09-16
WO1999046375A2 (de) 1999-09-16
JP2002505878A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
WO1999055858A3 (de) Menschliche nukleinsäuresequenzen aus pankreastumorgewebe
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
EP1308459A3 (de) Vollständige cDNA-Sequenzen
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1440981A3 (de) Vollständige humane cDNS
WO1999038972A8 (en) Human genes and gene expression products ii
WO2002002624A3 (en) B7-like molecules and uses thereof
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO1998059040A3 (de) Humane katalytische telomerase-untereinheit und deren diagnostische und therapeutische verwendung
WO1999054460A3 (de) Menschliche nukleinsäuresequenzen aus normalem blasengewebe
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO2001042474A3 (en) Interferon-like molecules and uses thereof
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO1999047655A3 (de) Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2005011725A3 (fr) Agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999920546

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09623746

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999920546

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1999920546

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999920546

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载